AVTX- Avalo Therapeutics, Inc.

Name: Avalo Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 25 buys and 0 sells. AVTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Boyd Taylor	275.0K	$4.04M	-
Other	Doyle Mittie	47.8K	$702.7K	-679
CFO	Sullivan Christopher Ryan	19.1K	$281.0K	-
Other	Varki Paul	3.6K	$53.4K	-
Dir	Chan Mitchell	3.2K	$46.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Mar 23, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	11,000	$2.50	$27,527.48	+0.8%
Mar 19, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	1,981,219	$2.05	$4,058,380.18	+3.5%
Feb 3, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	1,256,282	$3.98	$5,000,002.36	+2.1%
Dec 10, 2019	Miller Joseph M50	Chief Financial Officer	Buy	2,598	$2.85	$7,397.81	+5.6%
Dec 10, 2019	Harrell James Archie Jr	Chief Commercial Officer	Buy	3,064	$2.85	$8,724.74	+35.8%
Dec 10, 2019	Calias Pericles	Chief Scientific Officer	Buy	2,913	$2.85	$8,294.77	+5.9%
Sep 6, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	2,200,000	$3.05	$6,706,000.00	+3.7%
Aug 30, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	41,764	$3.22	$134,554.26	+0.1%
Aug 27, 2019	Pedder Simon	Executive Chairman Of The Bd	Buy	6,734	$2.98	$20,100.32	+2.6%
Aug 19, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	12,184	$3.46	$42,189.23	-

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC